Skip to content

AbbVie ABBV Acquisitions

Acquisitions at other companies

Eli Lilly logo
Eli LillyLLY
$1.06B
Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.04B+304,000%
Cardinal Health logo
Cardinal HealthCAH
$42M-98.5%
McKesson logo
McKessonMCK
$4M-81.0%
Cencora logo
CencoraCOR
$4.71B+19.6%
Establishment Labs logo
Establishment LabsESTA
$0-100%

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$444.6B+34.7%
P/E122.3×+34.6×
P/S7.1×+1.4×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's acquisitions?
AbbVie (ABBV) reported acquisitions of $0 in Q1 2026.
How has AbbVie's acquisitions changed year-over-year?
AbbVie's acquisitions decreased by 100.0% year-over-year, from $204M to $0.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.